4//SEC Filing
Campbell David Alan 4
Accession 0001209191-22-001813
CIK 0001817713other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:21 PM ET
Size
5.4 KB
Accession
0001209191-22-001813
Insider Transaction Report
Form 4
Campbell David Alan
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2022-01-03+354,250→ 354,250 totalExercise: $20.24Exp: 2032-01-02→ Common Stock (354,250 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on January 1, 2023 and the balance will vest in equal monthly installments thereafter over a three year period.
Documents
Issuer
Janux Therapeutics, Inc.
CIK 0001817713
Entity typeother
Related Parties
1- filerCIK 0001864158
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:21 PM ET
- Size
- 5.4 KB